The invention discloses a hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis, wherein the composition is present in paste form containing 15.0 to 19.5% (w/w), preferably 16.0 to 19.5% (w/w), 16.5 to 19.5% (w/w), 17.0 to 18.5% (w/w) or 17.5 to 18.
The invention discloses a hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis, wherein the composition is present in paste form containing 15.0 to 19.5% (w/w), preferably 16.0 to 19.5% (w/w), 16.5 to 19.5% (w/w), 17.0 to 18.5% (w/w) or 17.5 to 18.5% (w/w), more preferred 16.5 to 19.0% (w/w) or 16.8 to 17.8% (w/w), especially preferred 16.5 to 17.5% (w/w), and wherein the composition comprises an extrusion enhancer.
대표청구항▼
1. A hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis and albumin as an extrusion enhancer, wherein the composition is present in paste form containing 15.0 to 19.5% (w/w) crosslinked gelatin and 0.5 to 5.0% (w/w) extrusion enhancer, wherein th
1. A hemostatic composition comprising crosslinked gelatin in particulate form suitable for use in hemostasis and albumin as an extrusion enhancer, wherein the composition is present in paste form containing 15.0 to 19.5% (w/w) crosslinked gelatin and 0.5 to 5.0% (w/w) extrusion enhancer, wherein the composition is present in a syringe, wherein the hemostatic composition has a mean extrusion force of 40 N or lower, wherein the hemostatic composition is free of polyethylene glycol, sorbitol, and glycerol, wherein (w/w) crosslinked gelatin is defined as the weight of dry crosslinked gelatin per weight of the hemostatic composition, and wherein (w/w) extrusion enhancer is defined as the weight of extrusion enhancer per weight of the hemostatic composition. 2. The hemostatic composition according to claim 1, wherein the crosslinked gelatin is glutaraldehyde-crosslinked gelatin or genipin-crosslinked gelatin. 3. The hemostatic composition according to claim 1, wherein the crosslinked gelatin is type B gelatin. 4. The hemostatic composition according to claim 1, wherein the crosslinked gelatin is present as granular material. 5. The hemostatic composition according to claim 1, wherein the crosslinked gelatin has a mean particle size of 100 to 1000 μm. 6. The hemostatic composition according to claim 1, wherein the composition contains thrombin. 7. The hemostatic composition to claim 1 for use in the treatment of an injury selected from the group consisting of a wound, a hemorrhage, a damaged tissue, a bleeding tissue, and a bone defect. 8. The hemostatic composition according to claim 1, wherein the composition contains 16.0 to 19.5% (w/w) crosslinked gelatin. 9. The hemostatic composition according to claim 1, wherein the composition contains 16.5 to 19.5% (w/w) crosslinked gelatin. 10. The hemostatic composition according to claim 1, wherein the composition contains 16.5 to 19.0% (w/w) crosslinked gelatin. 11. The hemostatic composition according to claim 1, wherein the composition contains 17.0 to 18.5% (w/w) crosslinked gelatin. 12. The hemostatic composition according to claim 1, wherein the composition contains 16.5 to 17.5% (w/w) crosslinked gelatin. 13. The hemostatic composition according to claim 1, wherein the composition has a mean extrusion force of 35 N or lower. 14. The hemostatic composition according to claim 1, wherein the composition has a mean extrusion force of 20 N or lower. 15. The hemostatic composition according to claim 1, wherein the composition is characterized by a mean extrusion force of 40 N or lower, wherein mean extrusion force corresponds to a force required to extrude the hemostatic composition from a 5 ml standard syringe having a cylindrical body with an inner diameter of 12.2 mm coupled with a luer having an inner nozzle lumen diameter of 2.54 mm, using a 100 N load cell operating at a cross-beam speed of 250 mm/min with a cross-beam displacement of 34 mm. 16. The hemostatic composition according to claim 1, wherein the albumin extrusion enhancer is included in the paste at a concentration of between 1% and 5% (w/w). 17. The hemostatic composition according to claim 1, wherein the albumin extrusion enhancer is included in the paste at a concentration of between 2% and 4.5% (w/w). 18. The hemostatic composition according to claim 1, wherein the albumin extrusion enhancer is included in the paste at a concentration of between 1.5% and 5% (w/w). 19. The hemostatic composition according to claim 1, wherein the albumin extrusion enhancer is included in the paste at a concentration of about 1.5% (w/w). 20. The hemostatic composition according to claim 1, wherein the albumin extrusion enhancer is included in the paste at a concentration of between 0.8% and 3.3% (w/w). 21. The hemostatic composition according to claim 1, wherein the composition has a mean extrusion force in the range of 15 to 30 N. 22. A kit for making a flowable paste of crosslinked gelatin for the treatment of an injury selected from the group consisting of a wound, a hemorrhage, a damaged tissue, and a bleeding tissue, comprising: a) a dry hemostatic composition comprising crosslinked gelatin in particulate form to be reconstituted to a flowable paste containing 15.0 to 19.5% (w/w) crosslinked gelatin, wherein (w/w) crosslinked gelatin is defined as the weight of dry crosslinked gelatin per weight of the flowable paste; andb) a pharmaceutically acceptable diluent for reconstitution of the hemostatic composition,wherein either the composition or the diluent comprises albumin in an amount which leads to an albumin concentration in the reconstituted paste of between 0.5 to 5.0% (w/w), wherein (w/w) albumin is defined as the weight of albumin per weight of the hemostatic composition, wherein the reconstituted paste has a mean extrusion force of 40 N or lower, and wherein the reconstituted paste is free of polyethylene glycol, sorbitol, and glycerol. 23. The kit according to claim 22, wherein the pharmaceutically acceptable diluent comprises a buffer or buffer system. 24. The kit according to claim 22, wherein the pharmaceutically acceptable diluent comprises thrombin. 25. The kit according to claim 22, wherein the pharmaceutically acceptable diluent contains a substance selected from the group consisting of NaCl, CaCl2, and sodium acetate. 26. A method of treating an injury selected from the group consisting of a wound, a hemorrhage, a damaged tissue, and a bleeding tissue, comprising administering a hemostatic composition according to claim 1 to the injury. 27. A method for providing a ready to use form of a hemostatic composition according to claim 1, wherein the hemostatic composition is provided in a first syringe and a diluent for reconstitution is provided in a second syringe, the first and the second syringe are connected to each other, and the fluid is brought into the first syringe to produce a flowable form of the hemostatic composition. 28. The method according to claim 27, wherein the flowable form of the hemostatic composition contains particles, where more than 50% (w/w) of the particles have a size of 100 to 1000 μm.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (134)
Kowanko Nicholas (618 S. Fifth St. Moorhead MN 56560), Adhesive composition and method.
Yeung Jeffrey E. (San Jose CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Rhee Woonza M. (Palo Alto CA), Anti-adhesion films and compositions for medical use.
Tay Sew-Wah (Plymouth MN) Schankereli Kemal (Stillwater MN) Holman Thomas (Minneapolis MN) Mische Hans (St. Cloud MN), Apparatus and method for sealing vascular punctures.
Tardy Michel (Lyons FRX) Tiollier Jerome (Lyons FRX) Tayot Jean-Louis (La Tour De Salvagny FRX), Biocompatible bioresorbable and non-toxic adhesive composition for surgical use.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Biologically inert, biocompatible-polymer conjugates.
Miyata Teruo (Tokyo NJ JPX) Rubin Albert L. (Englewood NJ) Stenzel Kurt H. (Englewood NJ) Dunn Michael W. (New Rochelle NY), Collagen drug delivery device.
Rhee Woonza M. (Palo Alto CA) Rao Prema R. (Los Gatos CA) Chu George H. (Cupertino CA) DeLustro Frank A. (Belmont CA) Harner Carol F. H. (Redwood Shores CA) Sakai Naomi (San Mateo CA) Schroeder Jacqu, Collagen-based bioadhesive compositions.
Silver Fred (Bangor PA) Sharma Vinay (Long Valley NJ) Berndt Dieter R. (Allenwood NJ) Marn Louis E. (Morris Plains NJ), Collagen-based wound dressing and method for applying same.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Rhee Woonza (Palo Alto CA) Wallace Donald G. (Menlo Park CA) Michaels Alan S. (Boston MA) Burns ; Jr. Ramon A. (Fremont CA) Fries Louis (Los Altos CA) DeLustro Frank (Belmont CA) Bentz Hanne (Newark , Collagen-polymer conjugates.
Henry Raymond L. (Grosse Pointe Woods MI), Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers an.
Palefsky Howard (Atherton CA) Pharriss Bruce B. (Palo Alto CA) Chu George (Cupertino CA), Composition of low type III content human placental collagen.
Olof Mikael Trollsas ; Donald G. Wallace ; Frank A. DeLustro, Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use.
Donald G. Wallace ; George H. Chu ; Jacqueline Anne Schroeder, Compositions and systems for forming high strength medical sealants, and associated methods of preparation and use.
Viegas Tacey X. (Ann Arbor MI) Reeve Lorraine E. (Dexter MI) Levinson Robert S. (Chesterfield MO), Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers.
Qian, Zhen; Osawa, A. Edward; Reich, Cary J.; Wallace, Donald G.; Shargill, Narinder S.; Vega, Felix, Dry hemostatic compositions and methods for their preparation.
Narotam Pradeep K.,CAX ; van Dellen James R.,ZAX ; O'Fee Robert P. ; McKinney ; III George W. ; Archibald Simon J. ; O'Grady Judith, Dural/meningeal repair product using collagen matrix.
Wallace, Donald G.; Reich, Cary J.; Shargill, Narinder S.; Vega, Felix; Osawa, A. Edward; Qian-Wallis, Zhen, Fragmented polymeric compositions and methods for their use.
Montes, Joseph G.; Rangan, Krishnaswamy Kasthuri; Radhakrishnan, Ramachandran; Sudarshan, Tirumalai Srinivas, In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide and platinum catalyst.
Wallace Donald G. (Menlo Park CA) McMullin Hugh (Pacifica CA) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Wallace Donald G. (Menlo Park) McMullin Hugh (Pacifica) Chu George (Cupertino CA), Injectable ceramic compositions and methods for their preparation and use.
Wallace Donald G. (Menlo Park CA) Reihanian Hertsel (San Francisco CA) Pharriss Bruce B. (Palo Alto CA) Braun William G. (Los Altos CA), Injectable implant composition having improved intrudability.
Rhee Woonza M. ; Berg Richard A. ; Chu George H. ; DeLustro Frank A. ; Jolivette Dan M. ; McCullough Kimberly A., Injectable or implantable biomaterials for filling or blocking lumens and voids of the body.
Etienne Schacht BE; An Van Den Bulcke BE; Bernard Delaey BE; Jean-Pierre Draye BE, Medicaments based on polymers composed of methacrylamide-modified gelatin.
Wahlig Helmut (Darmstadt DEX) Dingeldain Elvira (Dreieich DEX) Braun Dietrich (Darmstadt-Arheilgen DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Wahlig Helmut (Darmstadt DEX) Dingeldein Elvira (Dreieich DEX) Braun Dietrich (Darmstadt DEX), Medicinally useful, shaped mass of collagen resorbable in the body.
Goldberg Eugene P. (Gainesville FL) Yaacobi Yoseph (Gainesville FL), Method and composition for preventing surgical adhesions using a dilute solution of polymer.
Eibl Johann (Vienna ATX) Schwarz Otto (Vienna ATX) Elsinger Fritz (Vienna ATX) Wber Gnter (Oberwaltersdorf ATX) Philapitsch Anton (Ebenfurt ATX) Linnau Yendra (Vienna ATX) Dorner Friedrich (Vienna AT, Method of inactivating reproducible filterable pathogens in blood products as well as a method of producing blood produc.
Sawyer Philip N. (Brooklyn NY) Sawyer Philip M. (Menlo Park CA) Reich Cary J. (Laguna Hills CA), Methods for sealing of staples and other fasteners in tissue.
Song Suk-Zu (Moorpark CA) Morawiecki Andrew (Camarillo CA) Pierce Glenn F. (Thousand Oaks CA) Pitt Colin G. (Westlake Village CA), Multi-layered collagen film compositions for delivery of proteins and methods of using same.
Saferstein Lowell (Edison NJ) Wolf Stephen (Neshanic Station NJ) Kamp Lola (Highland Park NJ) Linsky Cary (East Brunswick NJ) Wiseman David (Highland Park NJ), Process for preparing a neutralized oxidized cellulose product and its method of use.
Sharma Vinay K. (12 Walnut Dr. Long Valley NJ 07853), Process of preparing microparticulate collagen, collagen-based products thereby and method of applying same.
Wallace Donald G. ; Cruise Gregory M. ; Rhee Woonza M. ; Schroeder Jacqueline Anne ; Coker ; III George T. ; Maroney Marcee M., Rapid gelling biocompatible polymer composition.
Wallace, Donald G.; Cruise, Gregory M.; Rhee, Woonza M.; Schroeder, Jacqueline Anne; Coker, III, George T.; Maroney, Marcee M.; Trollsas, Olof Mikael, Rapid-gelling biocompatible polymer composition and associated methods of preparation and use.
Kensey Kenneth (Chester Springs PA) Nash John E. (Downington PA) Evans Douglas (Devon PA), System for closing a percutaneous puncture formed by a trocar to prevent tissue at the puncture from herniating.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Fort Lee NJ) Eaton Alexander M. (Durham NC), Tissue bonding and sealing composition and method of using the same.
Bass Lawrence S. (Little Neck NY) Libutti Steven K. (Lido Beach NY) Eaton Alexander M. (New York NY), Tissue bonding and sealing composition and method of using the same.
Hermes Matthew E. (Easton CT) Muth Ross R. (Brookfield CT) Gustafson Darel L. (Shelton CT), Treating bioabsorbable surgical articles by coating with glycerine, polalkyleneoxide block copolymer and gelatin.
Tsouderos Yannis,FRX ; Deloffre Pascale,FRX ; Wierzbicki Michel,FRX, Use of strontium salts and pharmaceutical compositions thereof for the treatment of arthrosis.
Weldon Thomas D. (P.O. Box 5149 Aquadilla PR 00605) Larsen Charles E. (P.O. Box 5149 Aquadilla PR 00605), Wound treating device using an inflatable membrane and method for treating wounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.